BioCentury | Aug 10, 2009
Regulation

PEGging Krystexxa

...at the manufacturing facility, including an additional 0.22 micron filtration step. Krystexxa is manufactured by Bio-Technology General...
BioCentury | Jul 24, 2006
Company News

Foamix management update

...Business: Drug delivery Hired: David Schuz as SVP of IP, formerly VP of legal at Bio-Technology General...
BioCentury | Jul 26, 2004
Company News

Savient drug delivery, metabolic news

...SVNT plans to divest its Israeli operations, including subsidiary Bio-Technology General Ltd. (Rehovot, Israel), to focus on...
...derived from the human nerve growth protein prosaposin. Both compounds are in Phase II testing. Bio-Technology General...
BioCentury | Oct 6, 2003
Company News

Savient, Teva deal

...cash sum that approximates SVNT's Oct. 2 close of $6.14. This would value SVNT (formerly Bio-Technology General...
BioCentury | Oct 3, 2003
Company News

Savient, Teva in acquisition talks

...cash sum that "approximates" SVNT's Thursday close price of $6.14. This would value SVNT (formerly Bio-Technology General...
BioCentury | Jun 30, 2003
Company News

Savient management update

...Promoted: Dov Kanner to EVP and CTO from SVP, while remaining managing director of SVNT’s Bio-Technology General...
BioCentury | Jun 23, 2003
Company News

Bio-Technology General board of directors update

Bio-Technology General Corp. (BTGC), East Brunswick, N.J. Business: Drug delivery, Metabolic Appointed: Jeremy Hayward-Surry, retiring president of Pall Corp. ; and Stephen Jaeger, president, chairman and CEO of eBT International Inc. Retired: Dan Tolkowsky Departed:...
BioCentury | Mar 31, 2003
Company News

Bio-Technology General management update

Bio-Technology General Corp. (BTGC), East Brunswick, N.J. Business: Drug delivery, Metabolic Hired: Zeb Horowitz as SVP and CMO, formerly executive director and global head of arthritis and bone research at Novartis AG 's Novartis Pharmaceuticals...
BioCentury | Mar 10, 2003
Company News

Bio-Technology General management update

Bio-Technology General Corp. (BTGC), Iselin, N.J. Business: Metabolic, Ophthalmic Promoted: Robert Shaw to EVP and chief administrative officer, while remaining general counsel and secretary; and Andre Groenewegen to SVP, while remaining managing director of BTGC's...
BioCentury | Feb 17, 2003
Company News

Antares, Bio-Technology General, Ferring Pharmaceuticals deal

...ANTR, and ANTR will receive E1.5 million ($1.6 million). Antares Pharma Inc. (ANTR), Exton, Penn. Bio-Technology General Corp....
Items per page:
1 - 10 of 183
BioCentury | Aug 10, 2009
Regulation

PEGging Krystexxa

...at the manufacturing facility, including an additional 0.22 micron filtration step. Krystexxa is manufactured by Bio-Technology General...
BioCentury | Jul 24, 2006
Company News

Foamix management update

...Business: Drug delivery Hired: David Schuz as SVP of IP, formerly VP of legal at Bio-Technology General...
BioCentury | Jul 26, 2004
Company News

Savient drug delivery, metabolic news

...SVNT plans to divest its Israeli operations, including subsidiary Bio-Technology General Ltd. (Rehovot, Israel), to focus on...
...derived from the human nerve growth protein prosaposin. Both compounds are in Phase II testing. Bio-Technology General...
BioCentury | Oct 6, 2003
Company News

Savient, Teva deal

...cash sum that approximates SVNT's Oct. 2 close of $6.14. This would value SVNT (formerly Bio-Technology General...
BioCentury | Oct 3, 2003
Company News

Savient, Teva in acquisition talks

...cash sum that "approximates" SVNT's Thursday close price of $6.14. This would value SVNT (formerly Bio-Technology General...
BioCentury | Jun 30, 2003
Company News

Savient management update

...Promoted: Dov Kanner to EVP and CTO from SVP, while remaining managing director of SVNT’s Bio-Technology General...
BioCentury | Jun 23, 2003
Company News

Bio-Technology General board of directors update

Bio-Technology General Corp. (BTGC), East Brunswick, N.J. Business: Drug delivery, Metabolic Appointed: Jeremy Hayward-Surry, retiring president of Pall Corp. ; and Stephen Jaeger, president, chairman and CEO of eBT International Inc. Retired: Dan Tolkowsky Departed:...
BioCentury | Mar 31, 2003
Company News

Bio-Technology General management update

Bio-Technology General Corp. (BTGC), East Brunswick, N.J. Business: Drug delivery, Metabolic Hired: Zeb Horowitz as SVP and CMO, formerly executive director and global head of arthritis and bone research at Novartis AG 's Novartis Pharmaceuticals...
BioCentury | Mar 10, 2003
Company News

Bio-Technology General management update

Bio-Technology General Corp. (BTGC), Iselin, N.J. Business: Metabolic, Ophthalmic Promoted: Robert Shaw to EVP and chief administrative officer, while remaining general counsel and secretary; and Andre Groenewegen to SVP, while remaining managing director of BTGC's...
BioCentury | Feb 17, 2003
Company News

Antares, Bio-Technology General, Ferring Pharmaceuticals deal

...ANTR, and ANTR will receive E1.5 million ($1.6 million). Antares Pharma Inc. (ANTR), Exton, Penn. Bio-Technology General Corp....
Items per page:
1 - 10 of 183